At RDx, we are proactively updating our services menu to ensure we are providing the most advanced solutions and meeting our clients’ needs. We offer a wide offering of testing in the following categories:
SARS-CoV-2 (COVID-19) Testing
Coronaviruses are a large family of viruses that cause illness ranging from the common cold to life threatening diseases. RDx offers COVID-19 antibody testing and a multiplex laboratory test for the detection of SARS-CoV-2, the causative agent of COVID-19.
Clinical lab testing is one of the primary lines of defenses when it comes to protecting a patient’s general well-being since it plays a crucial role in the early detection, diagnosis, and treatment of disease in patients. RDx offers a wide variety of clinical tests from routine to customized to meet each patient’s need.
With the rise of the viral and bacterial infections, diseases, and antibiotic resistance each year, molecular testing is highly needed to deliver sensitive, accurate, and rapid results containing precise DNA/RNA information. RDx offers advanced molecular testing using Polymerase Chain Reaction (PCR) technology, which enables highly accurate and rapid identification of disease by identifying the exact causative pathogen by its DNA/RNA. Molecular testing includes: RPP, COVID, UTI, Women’s Health, and Wound .
Addiction treatment is a unique medical specialty and differs from practices that focus on infectious or short-term disease. RDx offers clinical leadership in addictionology physicians with decades of expertise, enables the ordering of specific tests for each patient, and offers a collaborative relationship with the lab to fully interpret the results.
RDx supports risk-bearing entities by applying laboratory tools and programs to achieve their quality goals. We provide critical support in the following areas of risk-based contracting: cost containment, risk adjustment, and quality measures.